Anne Mary-Quillet

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia.

The multi-faceted roles of MYC in the prognosis of chronic lymphocytic leukemia.

Journal: Leukemia & lymphoma

Published: January 02, 2025

Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy.

Co-expression of CD69, CD49d, CD279 and CD20 in chronic lymphocytic leukemia cells is a new biomarker of active disease before or under therapy.

Journal: Haematologica

Published: April 08, 2024

Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension.

Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension.

Journal: Journal of hypertension

Published: December 08, 2023

Integrated spatial and multimodal single-cell transcriptomics reveal patient-dependent cell heterogeneity in splenic marginal zone lymphoma.

Integrated spatial and multimodal single-cell transcriptomics reveal patient-dependent cell heterogeneity in splenic marginal zone lymphoma.

Journal: The Journal of pathology

Published: September 20, 2023

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling.

New pharmacodynamic parameters linked with ibrutinib responses in chronic lymphocytic leukemia: Prospective study in real-world patients and mathematical modeling.

Journal: PLoS medicine

Published: July 27, 2023

Lymphocyte migration and retention properties affected by ibrutinib in chronic lymphocytic leukemia.

Lymphocyte migration and retention properties affected by ibrutinib in chronic lymphocytic leukemia.

Journal: Haematologica

Published: November 28, 2022

Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers.

Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancers.

Journal: Oncoimmunology

Published: November 01, 2021

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse.

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse.

Journal: Biomarker research

Published: September 21, 2020

Lymphoma Heterogeneity Unraveled by Single-Cell Transcriptomics.

Lymphoma Heterogeneity Unraveled by Single-Cell Transcriptomics.

Journal: Frontiers in immunology

Published: August 21, 2020

Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies.

Population Pharmacokinetics of Ibrutinib and Its Dihydrodiol Metabolite in Patients with Lymphoid Malignancies.

Journal: Clinical pharmacokinetics

Published: April 25, 2020

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 24, 2019

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.

Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.

Journal: Blood

Published: January 18, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026